Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Johnson buys 4 further Pfizer brands

Johnson buys 4 further Pfizer brands

2nd January 2008

Pharmacy supplier Johnson & Johnson (J&J) is to acquire four consumer health brands from the Indian unit of manufacturer Pfizer.

Benadryl, Benylin, Caladryl and Listerine are to be transferred to J&J for 2.15 billion rupees (?27 million) following the company’s acquisition of Pfizer’s consumer healthcare firm in 2006.

At the time of the acquisition, chairman and chief executive officer of J&J William Weldon said the combination had created the world’s top consumer health company.

However, Pfizer India retained other brands, including Gelusil, Selsun and Waterbury’s Compound.

Kewal Handa, managing director of Pfizer, said the retained brands would continue to contribute to Pfizer India’s success.

“We believe that there is tremendous potential in our brands, and business strategies will be put in place to maximize the opportunities and drive growth in the consumer health business,” he explained.

J&J operates in 57 countries and employs around 120,500 staff. During 2006, it achieved worldwide sales of $53.3 billion (?27 billion).

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.